We subsequently confirmed their modulation at the protein level by immunohistochemistry (Figure 4A and 4B): cytoplasmic staining of CRABP1 was increased in follicular adenoma, and FABP4 expression was reduced in adenoma and further reduced in carcinoma. Here, FABP4 is linked to follicular thyroid adenoma.